Report cover image

Global Ertapenem Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 192 Pages
SKU # APRC20106095

Description

Summary

According to APO Research, The global Ertapenem Sodium for Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Ertapenem Sodium for Injection include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Unitech Biotech, Par Pharmaceutical, NorthStar Rx and Intelicure Lifesciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ertapenem Sodium for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Ertapenem Sodium for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Ertapenem Sodium for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ertapenem Sodium for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Ertapenem Sodium for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Ertapenem Sodium for Injection sales, projected growth trends, production technology, application and end-user industry.


Ertapenem Sodium for Injection Segment by Company

Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
Sichuan Pharmaceutical Preparation Co., Ltd.
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Qilu Anti Pharmaceutical Co., Ltd.
Hainan Herui Pharmaceutical Co., Ltd.
Unitech Biotech
Par Pharmaceutical
NorthStar Rx
Intelicure Lifesciences
EUGIA PHARMA INC
ACS DOBFAR SPA

Ertapenem Sodium for Injection Segment by Type

0.5g
1g

Ertapenem Sodium for Injection Segment by Application

Hospital
Clinic
Other

Ertapenem Sodium for Injection Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Sodium for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ertapenem Sodium for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ertapenem Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ertapenem Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ertapenem Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Ertapenem Sodium for Injection Market Size, 2020 VS 2024 VS 2031
1.3 Global Ertapenem Sodium for Injection Market Size Estimates and Forecasts (2020-2031)
1.4 Global Ertapenem Sodium for Injection Sales Estimates and Forecasts (2020-2031)
1.5 Global Ertapenem Sodium for Injection Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Ertapenem Sodium for Injection Market Dynamics
2.1 Ertapenem Sodium for Injection Industry Trends
2.2 Ertapenem Sodium for Injection Industry Drivers
2.3 Ertapenem Sodium for Injection Industry Opportunities and Challenges
2.4 Ertapenem Sodium for Injection Industry Restraints
3 Ertapenem Sodium for Injection Market by Manufacturers
3.1 Global Ertapenem Sodium for Injection Revenue by Manufacturers (2020-2025)
3.2 Global Ertapenem Sodium for Injection Sales by Manufacturers (2020-2025)
3.3 Global Ertapenem Sodium for Injection Average Sales Price by Manufacturers (2020-2025)
3.4 Global Ertapenem Sodium for Injection Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Ertapenem Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Ertapenem Sodium for Injection Manufacturers, Product Type & Application
3.7 Global Ertapenem Sodium for Injection Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Ertapenem Sodium for Injection Market CR5 and HHI
3.8.2 Global Top 5 and 10 Ertapenem Sodium for Injection Players Market Share by Revenue in 2024
3.8.3 2024 Ertapenem Sodium for Injection Tier 1, Tier 2, and Tier 3
4 Ertapenem Sodium for Injection Market by Type
4.1 Ertapenem Sodium for Injection Type Introduction
4.1.1 0.5g
4.1.2 1g
4.2 Global Ertapenem Sodium for Injection Sales by Type
4.2.1 Global Ertapenem Sodium for Injection Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Ertapenem Sodium for Injection Sales by Type (2020-2031)
4.2.3 Global Ertapenem Sodium for Injection Sales Market Share by Type (2020-2031)
4.3 Global Ertapenem Sodium for Injection Revenue by Type
4.3.1 Global Ertapenem Sodium for Injection Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Ertapenem Sodium for Injection Revenue by Type (2020-2031)
4.3.3 Global Ertapenem Sodium for Injection Revenue Market Share by Type (2020-2031)
5 Ertapenem Sodium for Injection Market by Application
5.1 Ertapenem Sodium for Injection Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Ertapenem Sodium for Injection Sales by Application
5.2.1 Global Ertapenem Sodium for Injection Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Ertapenem Sodium for Injection Sales by Application (2020-2031)
5.2.3 Global Ertapenem Sodium for Injection Sales Market Share by Application (2020-2031)
5.3 Global Ertapenem Sodium for Injection Revenue by Application
5.3.1 Global Ertapenem Sodium for Injection Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Ertapenem Sodium for Injection Revenue by Application (2020-2031)
5.3.3 Global Ertapenem Sodium for Injection Revenue Market Share by Application (2020-2031)
6 Global Ertapenem Sodium for Injection Sales by Region
6.1 Global Ertapenem Sodium for Injection Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Ertapenem Sodium for Injection Sales by Region (2020-2031)
6.2.1 Global Ertapenem Sodium for Injection Sales by Region (2020-2025)
6.2.2 Global Ertapenem Sodium for Injection Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Ertapenem Sodium for Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Ertapenem Sodium for Injection Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Ertapenem Sodium for Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Ertapenem Sodium for Injection Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Ertapenem Sodium for Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Ertapenem Sodium for Injection Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Ertapenem Sodium for Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Ertapenem Sodium for Injection Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Ertapenem Sodium for Injection Revenue by Region
7.1 Global Ertapenem Sodium for Injection Revenue by Region
7.1.1 Global Ertapenem Sodium for Injection Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Ertapenem Sodium for Injection Revenue by Region (2020-2025)
7.1.3 Global Ertapenem Sodium for Injection Revenue by Region (2026-2031)
7.1.4 Global Ertapenem Sodium for Injection Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Ertapenem Sodium for Injection Revenue (2020-2031)
7.2.2 North America Ertapenem Sodium for Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Ertapenem Sodium for Injection Revenue (2020-2031)
7.3.2 Europe Ertapenem Sodium for Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Ertapenem Sodium for Injection Revenue (2020-2031)
7.4.2 Asia-Pacific Ertapenem Sodium for Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Ertapenem Sodium for Injection Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Ertapenem Sodium for Injection Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
8.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Comapny Information
8.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview
8.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
8.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments
8.2 Sichuan Pharmaceutical Preparation Co., Ltd.
8.2.1 Sichuan Pharmaceutical Preparation Co., Ltd. Comapny Information
8.2.2 Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview
8.2.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
8.2.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments
8.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
8.3.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Comapny Information
8.3.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
8.3.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
8.3.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
8.4 Qilu Anti Pharmaceutical Co., Ltd.
8.4.1 Qilu Anti Pharmaceutical Co., Ltd. Comapny Information
8.4.2 Qilu Anti Pharmaceutical Co., Ltd. Business Overview
8.4.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
8.4.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments
8.5 Hainan Herui Pharmaceutical Co., Ltd.
8.5.1 Hainan Herui Pharmaceutical Co., Ltd. Comapny Information
8.5.2 Hainan Herui Pharmaceutical Co., Ltd. Business Overview
8.5.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
8.5.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments
8.6 Unitech Biotech
8.6.1 Unitech Biotech Comapny Information
8.6.2 Unitech Biotech Business Overview
8.6.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
8.6.5 Unitech Biotech Recent Developments
8.7 Par Pharmaceutical
8.7.1 Par Pharmaceutical Comapny Information
8.7.2 Par Pharmaceutical Business Overview
8.7.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
8.7.5 Par Pharmaceutical Recent Developments
8.8 NorthStar Rx
8.8.1 NorthStar Rx Comapny Information
8.8.2 NorthStar Rx Business Overview
8.8.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
8.8.5 NorthStar Rx Recent Developments
8.9 Intelicure Lifesciences
8.9.1 Intelicure Lifesciences Comapny Information
8.9.2 Intelicure Lifesciences Business Overview
8.9.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
8.9.5 Intelicure Lifesciences Recent Developments
8.10 EUGIA PHARMA INC
8.10.1 EUGIA PHARMA INC Comapny Information
8.10.2 EUGIA PHARMA INC Business Overview
8.10.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
8.10.5 EUGIA PHARMA INC Recent Developments
8.11 ACS DOBFAR SPA
8.11.1 ACS DOBFAR SPA Comapny Information
8.11.2 ACS DOBFAR SPA Business Overview
8.11.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
8.11.5 ACS DOBFAR SPA Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Ertapenem Sodium for Injection Value Chain Analysis
9.1.1 Ertapenem Sodium for Injection Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Ertapenem Sodium for Injection Production Mode & Process
9.2 Ertapenem Sodium for Injection Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Ertapenem Sodium for Injection Distributors
9.2.3 Ertapenem Sodium for Injection Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.